M. Murakoshi et al., IMMUNOHISTOCHEMICAL STUDY OF ANDROGEN RECEPTOR IN RAT PROSTATIC HYPERPLASIA - EFFECT OF ANTIANDROGEN TZP-4238, Acta histochemica et cytochemica, 27(1), 1994, pp. 75-80
The effect of a synthetic steroidal anti-androgen, TZP-4238, on steroi
d-induced rat dorsolateral prostatic hyperplasia was investigated. Mal
e Sprague-Dawley rats were divided into five experimental groups. Grou
p 1 consisted of intact controls. The other animals were castrated. Th
e castrated animals were treated for seven weeks with 1) testosterone
1 mg/animal plus 17 beta-estradiol(E(2)) 10 mu g/animal (Group 2), 2)t
estosterone plus E(2) plus TZP-4238 2 mg/kg (Group 3), 3) testosterone
plus E(2) plus TZP-4238 8 mg/kg (Group 4) and 4) testosterone plus E(
2) plus Tween 80 (Group 5) instead of TZP-4238. TZP-4238 was administe
red orally for four weeks after three weeks of treatment with testoste
rone plus E(2). In groups 2 and 5, glandular hyperplasia of the dorsol
ateral prostate was clearly observed, and the fibro-muscular stromal p
roliferation was also noted. The glandular epithelial cells showed uni
formly intense nuclear immunostaining for androgen receptors (AR). Fur
thermore, AR was also localized in the nuclei of the proliferated fibr
omuscular cells. In contrast, combined treatment with TZP-4238 (Groups
3 and 4) produced inhibition of the glandular hyperplasia. Furthermor
e, nuclear immunostaining of AR of both epithelial and stromal cells w
as remarkably decreased. These results indicate that the uptake of tes
tosterone and/or its androgenic effect on the dorsolateral prostate ma
y be suppressed by TZP-4238. Furthermore, the decreased AR immunostain
ing may be explained by the decrease in number of AR and/or antibody b
inding site for AR.